Manufacturer:

Hikma

Name:

ADRIAMYCIN

Category:

J Code

HCPCS:

J9000

NDC(s):

00069-3030-20, 00069-3031-20, 00069-3032-20, 00069-3033-20, 00069-3034-20, 00069-4004-05, 00069-4015-10, 00069-4026-25, 00069-4037-01, 00143-9084-01, 00143-9085-01, 00143-9086-01, 00143-9087-01, 00143-9088-01, 00143-9089-01, 00143-9090-01, 00143-9091-01, 00143-9092-01, 00143-9093-01, 00143-9277-01, 16714-0001-01, 45963-0733-55, 45963-0733-57, 45963-0733-60, 45963-0733-68, 62756-0826-40, 62756-0827-40, 63323-0101-61, 63323-0883-05, 63323-0883-10, 63323-0883-30, 67457-0436-50, 70860-0208-25, 70860-0208-51, 00143-9369-01, 00143-9549-01, 00143-9370-01, 00143-9371-01, 00143-9548-01, 00143-9372-01, 00143-9547-01, 25021-0207-25, 00143-9275-01, 25021-0207-05, 25021-0207-51, 00143-9546-01,

Primary Type:

Cancer

Route of Administration:

Intravenous

About:

ADRIAMYCIN is a Cancer drug manufactured by Hikma and administered via the Intravenous route of administration. The J Code: J9000 is aligned to the drug ADRIAMYCIN.